Concepedia

Author

Cécile Dalban

Centre Georges François Leclerc

Also Known As

C Dalban, C. Dalban, Cecile Dalban, Cécile Dalban, Cécile Dalban, D Costagliola, Dalban, Cécile, J Mackey, Stephane Lastere, Xavier Duval

143

Publications

3K

Citations

29

H-Index

66

Concepts

All Affiliations

Centre Georges François LeclercInstitut Gustave RoussyInsermCentre Léon BérardSorbonne Université
CD

About

Cécile Dalban is an author at Centre Georges François Leclerc specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

20

939

2

Health Sciences

3

3

184

3

Natural Sciences

1

1

60

4

Public Health

1

1

48

5

Epidemiology

1

1

61

Cécile Dalban

×

50

Publications

2.8K

Citations

29

H-Index

YearCitations

Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer

Maximilien Barret, S. Antoun, Cécile Dalban,

Nutrition and Cancer

2014

241

Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma

Raphaël Maréchal, Jean‐Baptiste Bachet, John R. Mackey,

Gastroenterology

2012

236

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

Marine Fidelle, Conrad Rauber, Carolina Alves Costa Silva,

Science

2023

190

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

Ronan Flippot, Cécile Dalban, Brigitte Laguerre,

Journal of Clinical Oncology

2019

157

Evaluation of a peer support group therapy for HIV-infected adolescents

Isabelle Funck-Brentano, Cécile Dalban, Florence Veber,

AIDS

2005

137

Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer

Philippe A. Cassier, Raúl Navaridas, Mélanie Bellina,

Nature

2023

131

Nutritional Status Affects Treatment Tolerability and Survival in Metastatic Colorectal Cancer Patients: Results of an AGEO Prospective Multicenter Study

Maximilien Barret, David Malka, Thomas Aparicio,

Oncology

2011

107

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

Sylvain Ladoire, Frédérique Penault‐Llorca, Laura Senovilla,

Autophagy

2015

100

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF

Bruno Chauffert, L. Feuvret, Franck Bonnetain,

Annals of Oncology

2014

94

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

Roland Landman, Ricarda Schiemann, Safiatou Thiam,

AIDS

2003

90

Page 1